Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status now indicates recruitment is closed. The page adds help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, along with a revision footer change from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check17 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new version of the page. This appears to be a small maintenance update rather than changes to the study content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a new version of the page.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, indicating a versioned update of the site UI rather than a change to the trial information.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check96 days agoChange DetectedAdded Hepatocellular carcinoma to the page content and included a new resource link to the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.